Skip to main content
. 2010 Sep 7;5(9):e12577. doi: 10.1371/journal.pone.0012577

Figure 2. IL-2 and MCP-2 production in response to RD1 selected peptides and QFT-antigen in HIV-infected individuals.

Figure 2

IL-2 (A) and MCP-2 (B) release in response to the RD1 selected peptides and QFT-antigen was evaluated at day 1 in the whole blood of patients with or without active TB. Horizontal lines indicate the median production. White circles indicate the individuals without active TB, black circles indicate the patients with active TB. No significant differences were found among the different comparisons performed.